To properly prognosticate patients with COVID-19 at admission, the cutoff threshold of abnormality for high-sensitivity cardiac troponin I, CK-MB, (NT-pro)BNP, CK, and MYO (myoglobin) was analyzed as about 50% lower for most of the markers. This evidence concerns the gene TNNI3 and COVID-19.